| Identification | Back Directory | [Name]
LYN-1604 dihydrochloride | [CAS]
2310109-38-5 | [Synonyms]
LYN-1604 dihydrochloride
LYN-1604 2HCl 2216753-86-3(HCl) | [Molecular Formula]
C33H44Cl3N3O2 | [MDL Number]
MFCD32690067 | [MOL File]
2310109-38-5.mol | [Molecular Weight]
621.08 |
| Hazard Information | Back Directory | [Description]
LYN-1604 dihydrochloride is a potent UNC-51-like kinase 1 (ULK1) activator for the research of triple negative breast cancer (TNBC). | [Uses]
LYN-1604 dihydrochloride is a potent UNC-51-like kinase 1 (ULK1) activator (EC50=18.94 nM) for the research of triple negative breast cancer (TNBC)[1]. | [in vivo]
LYN-1604 (low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg; intragastric administration once a day for 14 days) inhibits the growth of xenograft TNBC by targeting ULK1-modulated cell death[1]. | Animal Model: | 24 female nude mice (BALB/c, 6-8 weeks, 20-22 g)[1] | | Dosage: | Low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg | | Administration: | Intragastric administration; once a day for 14 days | | Result: | Significantly inhibited the growth of xenograft MDA-MB-231 cells. The body weights of mice were stable. By the end of the experiment, the liver and spleen weight indexes of mice were slightly increased in parts of the groups, while the kidney weight index was not affected in all dose groups. |
| [IC 50]
ULK1: 18.94 nM (EC50) | [storage]
Store at -20°C | [References]
[1] Zhang L, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017 Apr 1;8(4):2687-2701. DOI:10.1039/c6sc05368h |
|
| Company Name: |
R&D Systems, Inc
|
| Tel: |
18003437475 18003437475 |
| Website: |
www.rndsystems.com |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|